Clinical Trial Update: Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates sequencing fludarabine followed by alemtuzumab in patients with chronic lymphocytic leukemia, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Alemtuzumab (Alemtuzumab)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia | Phase 2 | Status: COMPLETED